antheia.bioHealthcareFounded: 2013Funding to Date: $136.64MM
Antheia is the developer of a novel whole-cell engineering approach to reconstruct complex molecules in yeast and a platform designed to enables the discovery and manufacturing of plant-inspired drugs of unprecedented complexity and diversity.
For more details on financing and valuation for Antheia, register or login.
View Enterprise Value for Antheia.
To read this article and more news on Antheia, register or login.